血清低密度脂蛋白胆固醇水平与遗传多态性、肠道菌群和营养关系的研究。

IF 1.3 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL
Metabolic syndrome and related disorders Pub Date : 2024-03-01 Epub Date: 2023-11-16 DOI:10.1089/met.2023.0094
Asu Şevval Dural, Can Ergün, Murat Urhan
{"title":"血清低密度脂蛋白胆固醇水平与遗传多态性、肠道菌群和营养关系的研究。","authors":"Asu Şevval Dural, Can Ergün, Murat Urhan","doi":"10.1089/met.2023.0094","DOIUrl":null,"url":null,"abstract":"<p><p><b><i>Background:</i></b> To prevent cardiovascular disease (CVD), it is important to determine the factors that are associated with its development. High serum low-density lipoprotein (LDL) cholesterol (LDL-C) levels are a modifiable prevention and treatment target known to contribute to the development of CVD, but the factors affecting blood cholesterol levels, including LDL-C, remain controversial. <b><i>Objective:</i></b> In this study, the factors (genetic, nutritional, and gut microbiota) thought to be effective on serum LDL-C levels were discussed from a holistic perspective, and the effects of the relationship between these factors on LDL-C levels were examined. <b><i>Methods:</i></b> The study was carried out with 609 adults (48% male) who applied to a private health institution between 2016 and 2022. <b><i>Results:</i></b> It was observed that serum LDL-C levels were positively correlated with body mass index (BMI) (<i>P</i> = 0.000) and different ApoE alleles had significant effects on LDL-C levels. It was observed that the highest LDL-C levels were in the ɛ4+ group, followed by ɛ3+ and ɛ2+ groups, respectively (<i>P</i> = 0.000). Results showed that dietary cholesterol and fiber consumption did not significantly affect serum LDL-C levels (<i>P</i> = 0.705 and <i>P</i> = 0.722, respectively). It was also observed that enterotypes and the butyrate synthesis potential of intestinal microbiota did not cause significant changes in serum LDL-C levels (<i>P</i> = 0.369 and <i>P</i> = 975, respectively). <b><i>Conclusion:</i></b> Serum LDL-C levels are affected by modifiable factors such as BMI and nonmodifiable factors such as APOE genotype. By identifying these factors and conducting further studies on them, new ways to improve serum LDL-C levels, which is an important factor in the development of CVD, can be identified. In addition, no significant effect of gene-nutrient or microbiota-nutrient interactions on serum LDL-C levels was detected. Further research is needed, especially on the relationship between intestinal microbiota and serum LDL levels.</p>","PeriodicalId":18405,"journal":{"name":"Metabolic syndrome and related disorders","volume":" ","pages":"133-140"},"PeriodicalIF":1.3000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Investigation of the Relationship Between Serum Low-Density Lipoprotein Cholesterol Levels with Genetic Polymorphisms, Gut Microbiota, and Nutrition.\",\"authors\":\"Asu Şevval Dural, Can Ergün, Murat Urhan\",\"doi\":\"10.1089/met.2023.0094\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b><i>Background:</i></b> To prevent cardiovascular disease (CVD), it is important to determine the factors that are associated with its development. High serum low-density lipoprotein (LDL) cholesterol (LDL-C) levels are a modifiable prevention and treatment target known to contribute to the development of CVD, but the factors affecting blood cholesterol levels, including LDL-C, remain controversial. <b><i>Objective:</i></b> In this study, the factors (genetic, nutritional, and gut microbiota) thought to be effective on serum LDL-C levels were discussed from a holistic perspective, and the effects of the relationship between these factors on LDL-C levels were examined. <b><i>Methods:</i></b> The study was carried out with 609 adults (48% male) who applied to a private health institution between 2016 and 2022. <b><i>Results:</i></b> It was observed that serum LDL-C levels were positively correlated with body mass index (BMI) (<i>P</i> = 0.000) and different ApoE alleles had significant effects on LDL-C levels. It was observed that the highest LDL-C levels were in the ɛ4+ group, followed by ɛ3+ and ɛ2+ groups, respectively (<i>P</i> = 0.000). Results showed that dietary cholesterol and fiber consumption did not significantly affect serum LDL-C levels (<i>P</i> = 0.705 and <i>P</i> = 0.722, respectively). It was also observed that enterotypes and the butyrate synthesis potential of intestinal microbiota did not cause significant changes in serum LDL-C levels (<i>P</i> = 0.369 and <i>P</i> = 975, respectively). <b><i>Conclusion:</i></b> Serum LDL-C levels are affected by modifiable factors such as BMI and nonmodifiable factors such as APOE genotype. By identifying these factors and conducting further studies on them, new ways to improve serum LDL-C levels, which is an important factor in the development of CVD, can be identified. In addition, no significant effect of gene-nutrient or microbiota-nutrient interactions on serum LDL-C levels was detected. Further research is needed, especially on the relationship between intestinal microbiota and serum LDL levels.</p>\",\"PeriodicalId\":18405,\"journal\":{\"name\":\"Metabolic syndrome and related disorders\",\"volume\":\" \",\"pages\":\"133-140\"},\"PeriodicalIF\":1.3000,\"publicationDate\":\"2024-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Metabolic syndrome and related disorders\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1089/met.2023.0094\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/11/16 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Metabolic syndrome and related disorders","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1089/met.2023.0094","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/11/16 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

摘要

背景:为了预防心血管疾病(CVD),确定与其发展相关的因素是很重要的。高血清低密度脂蛋白(LDL)胆固醇(LDL- c)水平是一种可改变的预防和治疗目标,已知有助于心血管疾病的发展,但影响血液胆固醇水平的因素,包括LDL- c,仍然存在争议。目的:从整体角度探讨影响血清LDL-C水平的因素(遗传、营养和肠道微生物群),并探讨这些因素对LDL-C水平的影响关系。方法:研究对象为2016年至2022年间申请私立卫生机构的609名成年人(48%为男性)。结果:血清LDL-C水平与体重指数(BMI)呈正相关(P = 0.000),不同ApoE等位基因对LDL-C水平有显著影响。我们观察到,LDL-C水平最高的是[4+]组,其次是[3+]组和[2+]组(P = 0.000)。结果表明,膳食胆固醇和纤维摄入量对血清LDL-C水平无显著影响(P = 0.705和P = 0.722)。肠道菌群的肠道类型和丁酸盐合成电位对血清LDL-C水平无显著影响(P = 0.369和P = 975)。结论:血清LDL-C水平受BMI等可改变因素和APOE基因型等不可改变因素的影响。通过识别这些因素并对其进行进一步的研究,可以找到改善血清LDL-C水平的新途径,而LDL-C水平是CVD发生发展的重要因素。此外,基因-营养素或微生物-营养素相互作用对血清LDL-C水平没有显著影响。需要进一步的研究,特别是肠道微生物群与血清LDL水平的关系。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Investigation of the Relationship Between Serum Low-Density Lipoprotein Cholesterol Levels with Genetic Polymorphisms, Gut Microbiota, and Nutrition.

Background: To prevent cardiovascular disease (CVD), it is important to determine the factors that are associated with its development. High serum low-density lipoprotein (LDL) cholesterol (LDL-C) levels are a modifiable prevention and treatment target known to contribute to the development of CVD, but the factors affecting blood cholesterol levels, including LDL-C, remain controversial. Objective: In this study, the factors (genetic, nutritional, and gut microbiota) thought to be effective on serum LDL-C levels were discussed from a holistic perspective, and the effects of the relationship between these factors on LDL-C levels were examined. Methods: The study was carried out with 609 adults (48% male) who applied to a private health institution between 2016 and 2022. Results: It was observed that serum LDL-C levels were positively correlated with body mass index (BMI) (P = 0.000) and different ApoE alleles had significant effects on LDL-C levels. It was observed that the highest LDL-C levels were in the ɛ4+ group, followed by ɛ3+ and ɛ2+ groups, respectively (P = 0.000). Results showed that dietary cholesterol and fiber consumption did not significantly affect serum LDL-C levels (P = 0.705 and P = 0.722, respectively). It was also observed that enterotypes and the butyrate synthesis potential of intestinal microbiota did not cause significant changes in serum LDL-C levels (P = 0.369 and P = 975, respectively). Conclusion: Serum LDL-C levels are affected by modifiable factors such as BMI and nonmodifiable factors such as APOE genotype. By identifying these factors and conducting further studies on them, new ways to improve serum LDL-C levels, which is an important factor in the development of CVD, can be identified. In addition, no significant effect of gene-nutrient or microbiota-nutrient interactions on serum LDL-C levels was detected. Further research is needed, especially on the relationship between intestinal microbiota and serum LDL levels.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Metabolic syndrome and related disorders
Metabolic syndrome and related disorders MEDICINE, RESEARCH & EXPERIMENTAL-
CiteScore
3.40
自引率
0.00%
发文量
74
审稿时长
6-12 weeks
期刊介绍: Metabolic Syndrome and Related Disorders is the only peer-reviewed journal focusing solely on the pathophysiology, recognition, and treatment of this major health condition. The Journal meets the imperative for comprehensive research, data, and commentary on metabolic disorder as a suspected precursor to a wide range of diseases, including type 2 diabetes, cardiovascular disease, stroke, cancer, polycystic ovary syndrome, gout, and asthma. Metabolic Syndrome and Related Disorders coverage includes: -Insulin resistance- Central obesity- Glucose intolerance- Dyslipidemia with elevated triglycerides- Low HDL-cholesterol- Microalbuminuria- Predominance of small dense LDL-cholesterol particles- Hypertension- Endothelial dysfunction- Oxidative stress- Inflammation- Related disorders of polycystic ovarian syndrome, fatty liver disease (NASH), and gout
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信